Dr David K Harper, M D | |
201 Le Phillip Ct, Concord, NC 28025-2900 | |
(704) 782-1127 | |
(704) 782-1207 |
Full Name | Dr David K Harper |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 43 Years |
Location | 201 Le Phillip Ct, Concord, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134129513 | NPI | - | NPPES |
39613 | Other | NC | BLUE CROSS BLUE SHIELD |
8939613 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 28926 (North Carolina) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cabarrus Eye Center Pa | 5991735706 | 10 |
News Archive
Today marks the one year anniversary of Pokémon GO's worldwide release that sent crowds hiking through parks, meandering into streets and walking for miles in search of Pokémon, those cute little digital characters that appear in real locations on your smartphone.
Three-quarters of refractory status epilepticus patients have a poor functional outcome, which is linked to drug-induced coma and severe encephalographic suppression, say US scientists.
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have used a novel method for analyzing brain-scan data to distinguish children with autism from typically developing children.
› Verified 5 days ago
Entity Name | Cabarrus Eye Center Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922063304 PECOS PAC ID: 5991735706 Enrollment ID: O20050820000117 |
News Archive
Today marks the one year anniversary of Pokémon GO's worldwide release that sent crowds hiking through parks, meandering into streets and walking for miles in search of Pokémon, those cute little digital characters that appear in real locations on your smartphone.
Three-quarters of refractory status epilepticus patients have a poor functional outcome, which is linked to drug-induced coma and severe encephalographic suppression, say US scientists.
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have used a novel method for analyzing brain-scan data to distinguish children with autism from typically developing children.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David K Harper, M D 201 Le Phillip Ct, Concord, NC 28025-2900 Ph: (704) 782-1127 | Dr David K Harper, M D 201 Le Phillip Ct, Concord, NC 28025-2900 Ph: (704) 782-1127 |
News Archive
Today marks the one year anniversary of Pokémon GO's worldwide release that sent crowds hiking through parks, meandering into streets and walking for miles in search of Pokémon, those cute little digital characters that appear in real locations on your smartphone.
Three-quarters of refractory status epilepticus patients have a poor functional outcome, which is linked to drug-induced coma and severe encephalographic suppression, say US scientists.
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have used a novel method for analyzing brain-scan data to distinguish children with autism from typically developing children.
› Verified 5 days ago
Allison Mcalpine Baker, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 645 Amalia St Ne, Concord, NC 28025 Phone: 704-295-3255 Fax: 704-295-7791 | |
Joshua Rheinbolt, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 645 Amalia St Ne, Concord, NC 28025 Phone: 704-295-3255 Fax: 704-295-7791 | |
Dr. Claxton Allen Baer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 201 Le Phillip Ct, Concord, NC 28025 Phone: 704-782-1127 Fax: 704-782-1207 | |
Buhilda Mcgriff, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1025 Vinehaven Dr Ne, Concord, NC 28025 Phone: 704-795-5588 Fax: 704-795-5591 | |
Dr. Kurt K Lark, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 201 Lephillip Court N.e., Concord, NC 28025 Phone: 704-782-1127 Fax: 704-782-1207 | |
Jason Paul Handler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 201 Lephillip Court, Ne, Concord, NC 28025 Phone: 704-782-1127 Fax: 704-782-1207 |